Pyxis Oncology, Inc. (PYXS) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Pyxis Oncology, Inc. (PYXS) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

PYXS Cash Flow Statement

Pyxis Oncology, Inc. (PYXS) cash flow statement — 7-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-18.21M	-26M	-10.43M	-13.28M	-17.26M	-22.54M	-19.29M	-14.66M	-3.01M	-20.71M	-15.25M	-17.58M	-11.03M	-26.84M	-17.39M	-20.56M	-23.71M	-27.68M	-12.17M	-7.29M
Operating CF Margin %	-	-	-94.46%	-	-612.16%	-	-	-	-	-128.27%	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-5.46%	-15.38%	45.95%	9.46%	-474.09%	-8.81%	-26.46%	16.6%	72.74%	22.84%	12.27%	14.47%	53.48%	3.03%	-42.88%	-182.07%	-928.51%	-47.77%	-284.24%	-
Net Income	-25.35M	-23.27M	-18.11M	-22M	-18.35M	-21.16M	-35.57M	-21.2M	-17.3M	-3.26M	-15.6M	-23.05M	-15.9M	-19.24M	-36.1M	-27.67M	-25.56M	-31.38M	-16.83M	-14.18M
Depreciation & Amortization	301K	459K	2.9M	527K	535K	552K	550K	731K	585K	1.12M	690K	523K	524K	190K	192K	200K	159K	158K	158K	159K
Stock-Based Compensation	5.53M	1.21M	2.08M	3.07M	3.02M	3.63M	2.77M	2.98M	2.87M	4.32M	3.21M	5.18M	3.67M	4.88M	3.9M	4.45M	4.01M	3.4M	3.11M	307K
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	-1.26M	0	0	0	0	0	0	0
Other Non-Cash Items	45K	-11K	-156K	-322K	-694K	-964K	19.62M	-1.47M	-1.47M	-1.12M	-1.25M	-1.33M	175K	-463K	9.55M	307K	316K	232K	566K	2.71M
Working Capital Changes	1.27M	-4.39M	2.86M	5.45M	-1.76M	-4.6M	-6.66M	4.3M	12.3M	-21.77M	-2.31M	1.09M	1.76M	-12.21M	5.07M	2.16M	-2.64M	-93K	824K	3.71M
Change in Receivables	0	0	0	0	-3M	0	0	0	8M	-8M	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	-1.72M	-5.9M	1.13M	344K	6.57M	-2.01M	-10K	-602K	3.18M	-1.36M	350K	-1.54M	-1.56M	-753K	-1.89M	-2.31M	5.76M	-9.9M	4.03M	974K
Cash from Investing	21.3M	16.37M	16.26M	11.47M	15.3M	15.82M	26.66M	-8K	4K	-18.5M	10.23M	6.57M	-22.25M	-99.39M	-1.86M	-4.27M	-129K	-146K	0	0
Capital Expenditures	0	0	0	-9K	0	0	0	0	0	-237K	0	-61K	-2.26M	-4.41M	-1.86M	-4.27M	-129K	-146K	0	0
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	1.47%	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	1K	0	-15.19M	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	-107.31M	0	0	0	0	0	0	0	0	6.66M	15.19M	0	0	0	0	0	0	0
Cash from Financing	9.99M	-25K	669K	-8K	-67K	0	50K	1.66M	110K	57.51M	-25K	-171K	6.13M	0	0	6K	1K	176K	154.9M	-1.71M
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	47K	0	740K	0	-67K	2K	0	1.48M	105K	57.46M	0	0	6.12M	0	0	0	0	0	152.3M	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	-67K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	9.95M	-25K	-71K	-8K	0	-2K	50K	176K	5K	49K	-25K	-171K	3K	0	0	6K	1K	176K	2.6M	-1.71M
Net Change in Cash	13.09M	-9.66M	6.5M	-1.81M	-2.03M	-6.71M	7.42M	-13.02M	-2.89M	18.3M	-5.05M	-11.18M	-27.16M	-126.23M	-19.25M	-24.82M	-23.84M	-27.65M	142.73M	-8.99M
Free Cash Flow	-18.21M	-26M	-10.43M	-13.29M	-17.26M	-22.54M	-19.29M	-14.66M	-3.01M	-20.95M	-15.25M	-17.64M	-13.29M	-31.25M	-19.25M	-24.82M	-23.84M	-27.82M	-12.17M	-7.29M
FCF Margin %	-	-	-94.46%	-	-612.16%	-	-	-	-	-129.73%	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-5.46%	-15.38%	45.95%	9.4%	-474.09%	-7.58%	-26.46%	16.88%	77.37%	32.96%	20.74%	28.92%	44.26%	-12.3%	-58.15%	-240.6%	-1057.09%	-47.22%	-284.24%	-
FCF per Share	-0.28	-0.41	-0.17	-0.21	-0.28	-0.37	-0.32	-0.24	-0.05	-0.41	-0.34	-0.43	-0.35	-0.88	-0.55	-0.76	-0.73	-0.86	-0.38	-0.23
FCF Conversion (FCF/Net Income)	0.72x	1.12x	0.58x	0.60x	0.94x	1.07x	0.54x	0.69x	0.17x	6.36x	0.98x	0.76x	0.69x	1.39x	0.48x	0.74x	0.93x	0.88x	0.72x	0.51x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	28K	20K	0	0	0	0	0	0